全文获取类型
收费全文 | 74521篇 |
免费 | 4698篇 |
国内免费 | 234篇 |
专业分类
耳鼻咽喉 | 941篇 |
儿科学 | 2322篇 |
妇产科学 | 1722篇 |
基础医学 | 10572篇 |
口腔科学 | 1834篇 |
临床医学 | 6847篇 |
内科学 | 15036篇 |
皮肤病学 | 1253篇 |
神经病学 | 7315篇 |
特种医学 | 3583篇 |
外国民族医学 | 20篇 |
外科学 | 10957篇 |
综合类 | 708篇 |
一般理论 | 43篇 |
预防医学 | 5341篇 |
眼科学 | 1688篇 |
药学 | 4261篇 |
中国医学 | 88篇 |
肿瘤学 | 4922篇 |
出版年
2022年 | 529篇 |
2021年 | 1155篇 |
2020年 | 848篇 |
2019年 | 1127篇 |
2018年 | 1351篇 |
2017年 | 1110篇 |
2016年 | 1388篇 |
2015年 | 1508篇 |
2014年 | 2085篇 |
2013年 | 2839篇 |
2012年 | 4246篇 |
2011年 | 4501篇 |
2010年 | 2478篇 |
2009年 | 2359篇 |
2008年 | 4164篇 |
2007年 | 4336篇 |
2006年 | 4232篇 |
2005年 | 4194篇 |
2004年 | 3813篇 |
2003年 | 3718篇 |
2002年 | 3532篇 |
2001年 | 1510篇 |
2000年 | 1494篇 |
1999年 | 1419篇 |
1998年 | 939篇 |
1997年 | 734篇 |
1996年 | 637篇 |
1995年 | 603篇 |
1994年 | 501篇 |
1993年 | 470篇 |
1992年 | 845篇 |
1991年 | 844篇 |
1990年 | 796篇 |
1989年 | 728篇 |
1988年 | 677篇 |
1987年 | 710篇 |
1986年 | 672篇 |
1985年 | 691篇 |
1984年 | 576篇 |
1983年 | 504篇 |
1982年 | 455篇 |
1981年 | 440篇 |
1980年 | 388篇 |
1979年 | 485篇 |
1978年 | 418篇 |
1977年 | 351篇 |
1976年 | 324篇 |
1975年 | 340篇 |
1974年 | 377篇 |
1973年 | 316篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
2.
Hommes Franziska Mohsenpour Amir Kropff Dana Pilgram Lisa Matusall Svenja von Philipsborn Peter Sell Kerstin 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(1):96-106
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Akteure der öffentlichen Gesundheit (Public Health) tragen wesentlich zu Gesundheitsschutz, -förderung und... 相似文献
3.
4.
5.
6.
7.
8.
9.
10.
J. Savige L. Amos Frank Ierino H. G. Mack R. C. Andrew Symons P. Hughes 《Ophthalmic genetics》2016,37(4):369-376
Background: Dense deposit disease and atypical hemolytic uremic syndrome are often caused by Complement Factor H (CFH) mutations. This study describes the retinal abnormalities in dense deposit disease and, for the first time, atypical haemolytic uremic syndrome. It also reviews our understanding of drusen pathogenesis and their relevance for glomerular disease. Methods: Six individuals with dense deposit disease and one with atypical haemolytic uremic syndrome were studied from 2 to 40 years after presentation. Five had renal transplants. All four who had genetic testing had CFH mutations. Individuals underwent ophthalmological review and retinal photography, and in some cases, optical coherence tomography, and further tests of retinal function. Results: All subjects with dense deposit disease had impaired night vision and retinal drusen or whitish-yellow deposits. Retinal atrophy, pigmentation, and hemorrhage were common. In late disease, peripheral vision was restricted, central vision was distorted, and there were scotoma from sub-retinal choroidal neovascular membranes and atypical serous retinopathy. Drusen were present but less prominent in the young person with atypical uremic syndrome due to a heterozygous CFH mutation. Conclusions: Drusen are common in forms of C3 glomerulopathy caused by compound heterozygous or heterozygous CFH mutations. They are useful diagnostically but also impair vision. Drusen have an identical composition to glomerular deposits. They are also identical to the drusen of age-related macular degeneration, and may respond to the same treatments. Individuals with a C3 glomerulopathy should be assessed ophthalmologically at diagnosis, and monitored regularly for vision-threatening complications. 相似文献